Page 29 - Read Online
P. 29
Sawabata et al. Pulmonary wedge resection for NSCLC
accompanying wedge resection for clinical stage IA lung cancer†. Eur non-small cell lung cancer: an Italian multicenter observational study.
J Cardiothorac Surg 2017;51:511-7. Lung Cancer 2014;84:248-53.
37. Kodama K, Doi O, Higashiyama M, Yokouchi H. Intentional 51. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K,
limited resection for selected patients with T1 N0 M0 non-small-cell Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A,
lung cancer: a single-institution study. J Thorac Cardiovasc Surg Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R,
1997;114:347-53. Itami J, Araki T. Stereotactic body radiotherapy (SBRT) for operable
38. Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional stage I non-small-cell lung cancer: can SBRT be comparable to
limited pulmonary resection for peripheral T1 N0 M0 small-sized surgery? Int J Radiat Oncol Biol Phys 2011;81:1352-8.
lung cancer. J Thorac Cardiovasc Surg 2003;125:924-8. 52. Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof
39. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota EM, Van Vulpen M, Schramel FM. Clinical outcomes in early-stage
N. Radical sublobar resection for small-sized non-small cell lung NSCLC treated with stereotactic body radiotherapy versus surgical
cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769- resection. Anticancer Res 2015;35:5607-14.
75. 53. Rosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW,
40. Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto Detterbeck FC, Boffa DJ. Lobectomy versus stereotactic body
M, Nagai K, Tada H, Mitsudomi T, Tsuboi M, Shibata T, Fukuda H; radiotherapy in healthy patients with stage I lung cancer. J Thorac
Japan Clinical Oncology Group Lung Cancer Surgical Study Group. Cardiovasc Surg 2016;152:44-54.
Radiographically determined noninvasive adenocarcinoma of the 54. Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA,
lung: survival outcomes of Japan Clinical Oncology Group 0201. J Wisnivesky JP. Outcomes after stereotactic body radiotherapy versus
Thorac Cardiovasc Surg 2013;146:24-30. limited resection in older patients with early-stage lung cancer. J
41. Moon Y, Lee KY, Moon SW, Park JK. Sublobar resection margin Thorac Oncol 2015;10:1201-6.
width does not affect recurrence of clinical N0 non-small cell lung 55. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus
cancer presenting as GGO-predominant nodule of 3 cm or less. World limited resection for T1 N0 non-small cell lung cancer. Lung Cancer
J Surg 2017;41:472-9. Study Group. Ann Thorac Surg 1995;60:615-22.
42. Sirzén F, Kjellén E, Sörenson S, Cavallin-Ståhl E. A systematic 56. Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata
overview of radiation therapy effects in non-small cell lung cancer. T, Nakamura S, Tada H, Tsuboi M. A phase III randomized trial of
Acta Oncol 2003;42:493-515. lobectomy versus limited resection for small-sized peripheral non-
43. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol
Yamashita T, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura 2010;40:271-4.
T, Hirokawa Y, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara 57. Suzuki K, Watanabe S, Mizusawa J, Moriya Y, Yoshino I, Tsuboi M,
R, Itami J, Yamada K. Stereotactic hypofractionated high-dose Mizutani T, Nakamura K, Tada H, Asamura H; Japan Lung Cancer
irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes Surgical Study Group (JCOG LCSSG). Predictors of non-neoplastic
in 245 subjects in a Japanese multiinstitutional study. Cancer lesions in lung tumours showing ground-glass opacity on thin-section
2004;101:1623-31. computed tomography based on a multi-institutional prospective
44. Davis JN, Medbery C 3rd, Sharma S, Perry D, Pablo J, D’Ambrosio study†. Interact Cardiovasc Thorac Surg 2015;21:218-23.
DJ, McKellar H, Kimsey FC, Chomiak PN, Mahadevan A. Stereotactic 58. Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M, Suzuki
body radiotherapy for early-stage non-small cell lung cancer: clinical K, Watanabe S, Asamura H. Limited resection for early-stage non-
outcomes from a National Patient Registry. J Radiat Oncol 2015;4:55- small cell lung cancer as function-preserving radical surgery: a
63. review. Jpn J Clin Oncol 2017;47:7-11.
45. Shibamoto Y, Hashizume C, Baba F, Ayakawa S, Miyakawa A, Murai 59. NCT00499330. Phase III randomized study of lobectomy versus
T, Takaoka T, Hattori Y, Asai R. Stereotactic body radiotherapy using sublobar resection in patients with small peripheral stage IA non-small
a radiobiology-based regimen for stage I non-small-cell lung cancer: cell lung cancer. Available from: https://www.georgiacancerinfo.org/
five-year mature results. J Thorac Oncol 2015;10:960-4. clinical-trials/lung-cancer/2591. [Last accessed on 28 Mar 2017].
46. Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki 60. Fernando HC, Landreneau RJ, Mandrekar SJ, Nichols FC, Hillman
N, Sonobe M, Nagata Y, Hiraoka M, Date H. Video-assisted SL, Heron DE, Meyers BF, DiPetrillo TA, Jones DR, Starnes SL,
thoracoscopic lobectomy versus stereotactic radiotherapy for stage I Tan AD, Daly BD, Putnam JB Jr. Impact of brachytherapy on local
lung cancer. Ann Thorac Surg 2015;99:1122-9. recurrence rates after sublobar resection: results from ACOSOG
47. Bhandari RP, Stanford JD, Packianathan S, Duggar WN, Z4032 (Alliance), a phase III randomized trial for high-risk operable
Kanakamedala MR, Zhang X, Giri SP, Kumar PP, Harrell LM, non-small-cell lung cancer. J Clin Oncol 2014;32:2456-62.
Mangana SH, Yang C, Vijayakumar S. Stereotactic body radiation 61. Takahashi N, Sawabata N, Kawamura M, Ohtsuka T, Horio
therapy for stage I non-small cell lung cancer: a retrospective, single- H, Sakaguchi H, Nakayama M, Yoshiya K, Chida M, Hoshi E.
center study of 55 patients. Oncology 2016;91:194-204. Multicenter prospective study of sublobar resection for c-stage I
48. Lischalk JW, Woo SM, Kataria S, Aghdam N, Paydar I, Repka MC, non-small cell lung cancer patients unable to undergo lobectomy
Anderson ED, Collins BT. Long-term outcomes of stereotactic body (KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg
radiation therapy (SBRT) with fiducial tracking for inoperable stage I 2016;64:470-5.
non-small cell lung cancer (NSCLC). J Radiat Oncol 2016;5:379-87. 62. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J,
49. Puri V, Crabtree TD, Bell JM, Broderick SR, Morgensztern D, Fakiris A, Bezjak A, Videtic G, Johnstone D, Fowler J, Gore E, Choy
Colditz GA, Kreisel D, Krupnick AS, Patterson GA, Meyers BF, H. Stereotactic body radiation therapy for inoperable early stage lung
Patel A, Robinson CG. Treatment outcomes in stage I lung cancer: cancer. JAMA 2010;303:1070-6.
a comparison of surgery and stereotactic body radiation therapy. J 63. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K,
Thorac Oncol 2015;10:1776-84. Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa
50. Ricardi U, Frezza G, Filippi AR, Badellino S, Levis M, Navarria P, K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura
Salvi F, Marcenaro M, Trovò M, Guarneri A, Corvò R, Scorsetti M. S. Prospective trial of stereotactic body radiation therapy for both
Stereotactic ablative radiotherapy for stage I histologically proven operable and inoperable T1N0M0 non-small cell lung cancer: Japan
22 Mini-invasive Surgery ¦ Volume 1 ¦ March 31, 2017